Thermo Fisher Scientific has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.
Thermo Fisher Scientific has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.
Athena Diagnostics, based in Worcester, Massachusetts, USA, has been sold to Quest Diagnostics for $740 million. The company is a reference laboratory that provides comprehensive diagnostic testing for neurological and other diseases.
Lancaster Laboratories, based in Lancaster, Pennsylvania, USA has been sold to Eurofins Scientific SE for $200 million, subject to a post-closing adjustment. The laboratory provides contract-testing services for pharmaceutical, biopharmaceutical and environmental sciences customers.
For more information go to www.thermofisher.com
Marking 150 Years: Shimadzu Europa’s President Reflects on Legacy and Innovation
June 24th 2025Yoshiaki Hirao, President of Shimadzu Europa GmbH, sat down with LCGC International to share insights into the company’s journey, reflecting on its evolution from a small Kyoto-based enterprise founded in 1875 to a global leader in analytical instrumentation.